CD8+ T cells are one of the most critical cell populations in the TME owing to their anti-tumor effects; furthermore, they play a crucial role in all stages of tumorigenesis, including the promotion of LPO and the induction of tumor ferroptosis by IFN-γ during the immunotherapies (21). The gene discussed is CD8A; the disease is neoplasm.